Academic background&position

data loading...

1. [SCIE] Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma [JOURNAL OF HEPATOLOGY] - 2025-05-01
2. [SCIE] Prognostic value of interim [68Ga]Ga-DOTA-TOC PET/CT in patients with neuroendocrine tumour who underwent peptide receptor radionuclide therapy [EUROPEAN RADIOLOGY] - 2025-05-01
3. [SCIE] Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab?bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan [JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY] - 2025-01-28
4. [SCIE] Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial [CANCER MEDICINE] - 2025-01-01
5. [SCIE] Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific [TARGETED ONCOLOGY] - 2024-11-01